Nuclera Case Study

Nuclera supports scientists to better human health by enabling rapid, easy access to proteins required for drug discovery research. The Company’s eProtein Discovery™ benchtop system accelerates protein expression and purification workflows within research labs. The system reduces the timelines and costs associated with protein expression and purification through automated construct screening to inform protein scale-up resulting in mg amounts in less than 48 hours. Integrating cell-free expression systems, novel digital microfluidics, and robust screening data, eProtein Discovery enables effortless multiplex protein screening and rapid access to even challenging proteins at high quality.

Zyme is supporting Nuclera’s global growth strategy and establishing the Company as a leader in the field. The communications strategy has focused on communicating the capabilities of eProtein Discovery in accelerating discovery workflows and building on the reputations of the Nuclera team as protein production experts in the industry.

As the Company has continued to expand following it’s $75M USD Series C raise, our approach has focused on demonstrating translatability and validation to potential pharma partners through highlighting successful outcomes of key partnerships and reaching potential investors and commercial partners through exposure in key life science trade business publications.

• Supported communications surrounding key company milestones, including Series C fundraise, expansion of system capabilities, partnerships, and international expansion, securing coverage across top life science publications such as Endpoints News, Fierce, STAT, BioCentury, MedNous, GEN, and GenomeWeb.
• Facilitated ongoing messaging development ensuring all external communications consistently articulate the value and differentiation of Nuclera’s technology.
• Established Nuclera’s senior team as thought leaders with interviews and articles in Drug Discovery News, Drug Discovery World, The Scientist, Labiotech, Biocompare, and Innovations in Pharmaceutical Technology.
• Implemented a strategic awards programme that delivered recognition for the Company, achieving inclusion in the Sifted UK & Ireland Leaderboard, multiple wins at the Cambridge Independent and Business Weekly Awards, and shortlisting in both the European Mediscience Awards and One Nucleus Awards.
• Maximised on Nuclera’s presence at key industry conferences, securing interviews and coverage with trade media such as Technology Networks, Drug Target Review and BioTechniques.
• Provided strategic social media support to spotlight major Company activities, strengthen engagement with core audiences, and drive traffic to the Nuclera website.